Up next

Autoplay

Ticagrelor delivers benefits, more bleeds in stable CAD and diabetes

0 Views • 08/17/25
Share
Side Effects
Side Effects
Subscribers
0

Patients with stable coronary artery disease and type 2 diabetes had fewer ischemic cardiovascular events on dual antiplatelet therapy with ticagrelor plus aspirin. But they also had more major bleeding events than patients taking placebo plus aspirin. At the annual congress of the European Society of Cardiology, Deepak Bhatt, MD, professor of medicine at Harvard Medical School, Boston, discussed the findings of the Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study (THEMIS). Find out more at www.mdedge.com.

Show more
0 Comments sort Sort By

Up next

Autoplay